BNP Paribas Hong Kong continues their support to HKU-Pasteur Research Centre - BNP Paribas Asia Pacific
BNP Paribas in Asia Pacific News & Press
""
June 20, 2011 -

BNP Paribas Hong Kong continues their support to HKU-Pasteur Research Centre

Forward to a friendForward to a friend PrintPrint

In line with the Group’s philanthropy policy, which is led by the BNP Paribas Foundation, BNP Paribas Corporate & Investment Banking (CIB) has renewed its partnership in Hong Kong with the HKU-Pasteur Research Centre.

 HKU-PRC ©
The donation will continue to fund the study of dengue virus, which aims to achieve a complete understanding of the molecular interactions between the virus and the host cells. Particular emphasis will be placed on the mechanisms regulating assembly, budding, trafficking and egress of dengue virus, as well as the immune response of the host to the virus.

“For the second consecutive year, BNP Paribas CIB Hong Kong is donating the allocated budget on year-end business gift to Institut Pasteur in supporting their studies in fighting infectious diseases. We hope that it will help not only address the challenges in preventing the spread of infectious diseases, but also fulfill our commitment to improve the wellbeing of the local communities in which we live and work,” said Paul Yang, Chief Executive Officer of BNP Paribas Hong Kong Branch. “In Hong Kong, our grant will support the training of young scientists who work on the related study of dengue virus at the HKU-Pasteur Research Centre. As education is our main field of action for the Asia Pacific region, this sponsorship echoes with our philanthropic focus.”

Dr Roberto Bruzzone, Chief Executive Officer, HKU-Pasteur Research Centre, added: “Dengue fever is endemic in more than 100 countries and raising temperatures may increase the geographical range of the disease for which there is no available treatment. It is a global problem and we feel it necessary to develop research programs that focus on the interactions of the virus with components of the infected cells for a better comprehension of the molecular mechanisms of disease pathogenesis and future drug discovery. These are risky projects that may not be easily funded through the conventional granting schemes. We are thrilled to continue our partnership with BNP Paribas CIB in this effort and thank them for sharing our vision and supporting this work.”

This partnership in Hong Kong is part of BNP Paribas CIB’s global sponsorship programme with Institut Pasteur – a nonprofit private foundation which contributes to the prevention and treatment of infectious diseases. This sponsorship programme, namely “CIB for Health and Medical Research”, was established in 2008 and the total global donation to date amount to 1.3 million euros. Besides the study in Hong Kong, BNP Paribas CIB also supports the Institut’s research programmes across twenty countries including vaccines against measles and HIV (France), hepatitis C (Japan, Spain), malaria (Brazil), polio (Russia) and tuberculosis (The Netherlands).

About BNP Paribas CIB
BNP Paribas Corporate and Investment Banking (CIB) (http//cib.bnpparibas.com/) has almost 20,000 employees deployed in over 50 countries around the world and serves 13,000 corporate and institutional clients. BNP Paribas excels in three fundamental sectors in particular:
Derivatives – it is one of the leading global players in rates, credit, forex, commodity and equity derivatives.
Capital markets – it is amongst the top European institutions for both equity and debt activities (bond and equity issues, securitization, convertibles).
Structured finance – it is amongst the world leaders for export, asset, project and commodity finance.

About Institut Pasteur
Louis Pasteur created the Institut Pasteur in 1887 as a private non-profit foundation that rapidly became world-renowned for its biomedical research. The main aim of the Institut Pasteur is understanding and preventing diseases throughout the world through excellent scientific and public health research, teaching and other activities.

Together with its major contribution to a deeper understanding of fundamental aspects of life, Institut Pasteur continues to devote a large part of its efforts to infectious diseases, genetic disorders, neurodegenerative diseases and certain cancers. Close to 2,600 people work on its main campus in Paris, which is at the heart of an international network of 32 research institutes on 5 continents. Over the years, 10 scientists from Institut Pasteur have received the Nobel Prize.
www.pasteur.fr
www.aiderpasteur.fr


Press Contacts

Pascal Hénisse +33 1 40 14 65 14 pascal.henisse@bnpparibas.com
Lilian Kung +852 2909 8849 lilian.kung@asia.bnpparibas.com